Anastrozole Tablets — Class II drug recall D-1467-2019
Terminated recall by American Health Packaging, reported 2019-07-17, distributed nationwide. GMP Deviations: Potential cross contamination due to cleaning procedure failure.
| Recall number | D-1467-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | American Health Packaging, Columbus, OH, United States |
| Recall initiated | 2019-05-09 |
| Classified | 2019-07-10 |
| Reported by FDA | 2019-07-17 |
| Terminated | 2020-09-09 |
| Distributed | Nationwide (US) |
| Quantity | 375,921 bottles |
| Reason classes | cgmp |
| NDC | 68001-0155, 68001-0155-04, 68001-0155-08 |
| Lot numbers | M711214, M711215, M711216, M711217, M711218, M802197, M802198, M802199, M805203, M805204, M805207, M805209, M805946, M812455, M812456, M815766, M815767, M818273, M818633, M818634, M819857, M819858, M819859 |
| Expiration dates | 2019-03-31, 2019-08-31, 2020-01-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-10-31, 2020-11-30 |
Product
Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories
Reason for recall
GMP Deviations: Potential cross contamination due to cleaning procedure failure.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1467-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.